Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ASTRAZEN - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to IntraDay Trade List

IntraDay Trade Rating: 2.9

Here’s a detailed breakdown of ASTRAZEN’s intraday trading potential based on current metrics and technical indicators

📉 Technical & Momentum Snapshot

RSI (44.9): Below neutral, indicating weak momentum.

MACD (-20.8): Bearish crossover, suggesting downward pressure.

Volume (17,347 vs Avg 23,611): Lower than average, showing reduced intraday interest.

Price vs DMA: Trading below 50-DMA (8,995 ₹), which may act as resistance.

📈 Intraday Strategy

If considering a fresh intraday position

Optimal Buy Price: Around 8,820–8,850 ₹, ideally near intraday support.

Profit-Taking Targets

Target 1: 8,950 ₹ (minor resistance)

Target 2: 9,020 ₹ (stronger resistance zone)

Stop-Loss: 8,780 ₹ (below recent support and psychological level)

If already holding the stock intraday

Exit on Weakness: If price breaks below 8,800 ₹ with rising volume and MACD divergence.

Exit on Strength: If price nears 9,000 ₹ but RSI fails to cross 50—indicating limited upside.

⚠️ Risk Factors

Extremely High P/E (127) vs Industry PE (32): Valuation is stretched.

Bearish MACD & RSI: Weak technical momentum.

Low intraday volume: May lead to poor liquidity and execution.

Would you like to compare ASTRAZEN with another pharma stock or explore swing trading setups instead? I’ve got plenty of insights to share.

Edit in a page

Back to IntraDay Trade List